Hepatitis Forums

Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on December 06, 2019, 11:28:05 am

Title: Eight Weeks of Mavyret Cures Hep C at High Rate in Those With Cirrhosis
Post by: Hep Editors on December 06, 2019, 11:28:05 am

Among people with compensated cirrhosis (the milder form of the severe liver disease), eight weeks of treatment with Mavyret (glecaprevir/pibrentasvir) cures hepatitis C virus (HCV) at a high rate.

Robert S. Brown Jr., MD, MPH, the director of the Center for Liver Disease and Transplantation at Weill Cornell Medicine in New York City, led the research team behind the single-arm, multicenter, Phase IIIb EXPEDITION-8 trial. The 390 participants, who were all being treated for the virus for the first time, included 270 people with genotypes 1, 2 4, 5 and 6 and 60 people with genotype 3. All had compensated cirrhosis.

Read more...
https://www.hepmag.com/article/eight-weeks-mavyret-cures-hep-c-high-rate-cirrhosis